Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9


3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one (CHP) inhibits human ovarian cell proliferation by inducing apoptosis.

Lan QY, Liu QL, Cai J, Liu AW.

Int J Clin Exp Pathol. 2015 Jan 1;8(1):155-63. eCollection 2015.


A risk prediction model for smoking experimentation in Mexican American youth.

Talluri R, Wilkinson AV, Spitz MR, Shete S.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2165-74. doi: 10.1158/1055-9965.EPI-14-0467. Epub 2014 Jul 25.


A qualitative assessment of an online support community for ovarian cancer patients.

Gill PS, Whisnant B.

Patient Relat Outcome Meas. 2012;3:51-8. doi: 10.2147/PROM.S36034. Epub 2012 Oct 4.


Potential markers for detection and monitoring of ovarian cancer.

Rein BJ, Gupta S, Dada R, Safi J, Michener C, Agarwal A.

J Oncol. 2011;2011:475983. doi: 10.1155/2011/475983. Epub 2011 Apr 11.


Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer.

Gupta D, Lammersfeld CA, Vashi PG, Braun DP.

J Ovarian Res. 2010 Oct 12;3:22. doi: 10.1186/1757-2215-3-22.


Comparison of discriminatory power and accuracy of three lung cancer risk models.

D'Amelio AM Jr, Cassidy A, Asomaning K, Raji OY, Duffy SW, Field JK, Spitz MR, Christiani D, Etzel CJ.

Br J Cancer. 2010 Jul 27;103(3):423-9. doi: 10.1038/sj.bjc.6605759. Epub 2010 Jun 29.


Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature.

Gupta D, Lis CG.

J Ovarian Res. 2009 Oct 9;2:13. doi: 10.1186/1757-2215-2-13.


Segregation analysis of epithelial ovarian cancer in Finland.

Auranen A, Iselius L.

Br J Cancer. 1998 May;77(9):1537-41.


Cancer incidence in the first-degree relatives of ovarian cancer patients.

Auranen A, Pukkala E, Mäkinen J, Sankila R, Grénman S, Salmi T.

Br J Cancer. 1996 Jul;74(2):280-4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk